Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
22.11
+0.85 (4.00%)
At close: May 28, 2026, 4:00 PM EDT
22.49
+0.38 (1.72%)
After-hours: May 28, 2026, 5:39 PM EDT
Castle Biosciences Employees
Castle Biosciences had 942 employees as of March 31, 2026. The number of employees increased by 59 or 6.68% since the number was last reported on December 31, 2025.
Employees
942
Change
59
Growth
6.68%
Revenue / Employee
$360,849
Profits / Employee
-$13,622
Market Cap
670.60M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 942 | 59 | 6.68% | 942 | 0 |
| Dec 31, 2025 | 883 | 122 | 16.03% | 883 | 0 |
| Dec 31, 2024 | 761 | 151 | 24.75% | 761 | 0 |
| Dec 31, 2023 | 610 | 67 | 12.34% | 610 | 0 |
| Dec 31, 2022 | 543 | 198 | 57.39% | 542 | 1 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| CareDx | 765 |
| Adaptive Biotechnologies | 624 |
| Biodesix | 334 |
CSTL News
- 15 days ago - Castle Biosciences price target lowered to $40 from $50 at BTIG - TheFly
- 15 days ago - Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference - PRNewsWire
- 16 days ago - Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation - PRNewsWire
- 21 days ago - Castle Biosciences reports Q1 EPS , consensus (49c) - TheFly
- 21 days ago - Castle Biosciences raises 2026 revenue view to $345M-$355M from $340M-350M - TheFly
- 22 days ago - Castle Biosciences Earnings Call Transcript: Q1 2026 - Transcripts
- 22 days ago - Castle Biosciences Slides: Q1 2026 - Filings
- 22 days ago - Castle Biosciences Quarterly report: Q1 2026 - Filings